Skip to main content
logo
Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,420.00
-20.00 (-0.37%)
Oct 2, 2026, 3:30 PM KST

Kyongbo Pharmaceutical Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
279,552264,104238,556216,357196,265170,660
Revenue Growth
14.83%10.71%10.26%10.24%15.00%-20.73%
Gross Profit
107,473102,30489,27462,57643,86734,731
Operating Income
2,6333,51910,4545,5451,393-6,625
Net Income
5,045182.294,6392,974610.59-7,495
Earnings Per Share
211.217.63194.00124.4226.00-314.00
EPS Growth
1123.64%-96.07%55.93%378.52%--

Revenue by Segment
Fiscal YearFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '23 Dec '22 Dec '21 Dec '20
Raw Material
138,268139,990144,076125,164167,154
Finished Products
100,28976,36852,18945,49548,131

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
13,8288,0486,1285,3477,2184,290
Total Debt
158,001126,67191,43375,93664,51256,587
Net Cash (Debt)
-144,173-118,623-85,305-70,589-57,294-52,296
Net Cash Growth
------
Net Cash Per Share
-6035.76-4961.88-3567.15-2952.68-2439.66-2190.88

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
11,9537,456149.124,84410,12717,968
Capital Expenditures
-55,933-41,538-12,697-9,693-12,874-17,506
Free Cash Flow
-43,980-34,083-12,547-4,849-2,747461.73
Free Cash Flow Growth
------94.72%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
38.45%38.74%37.42%28.92%22.35%20.35%
Operating Margin
0.94%1.33%4.38%2.56%0.71%-3.88%
Pretax Margin
2.14%0.17%2.06%1.00%-0.31%-5.82%
Profit Margin
1.80%0.07%1.94%1.38%0.31%-4.39%
FCF Margin
-15.73%-12.90%-5.26%-2.24%-1.40%0.27%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
25.66756.7032.0567.44391.54-
P/FCF Ratio
-----556.60
PS Ratio
0.460.520.620.931.221.51